rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexat
Introduction and Objectives: Liver injury caused by methotrexate (MTX) has mostly been investigated ...
Background: Methotrexate, a drug used for rheumatic arthritis treatment is suspected to has hepatoto...
The objectives were to determine quantitative liver function prospectively in patients with rheumato...
BACKGROUND: Methotrexate-induced liver damage in psoriasis has led to dermatologic guidelines that s...
BACKGROUND AND DESIGN: Methotrexate (MTX) hepatotoxicity in psoriatic patients is well recognized, b...
Background:Methotrexate (MTX) is one of the most commonly used disease-modifying antirheumatic drugs...
Background Rheumatoid arhtirtis (RA) is a chronic autoimmune disease that mainly attacks joints. It ...
Contains fulltext : 50706.pdf (publisher's version ) (Closed access)BACKGROUND: Me...
The present study was undertaken to evaluate methotrexate induced early hepatotoxicity in rheumatoid...
of procollagen III peptide as a marker of hepatotoxicity in MTX-treated psoriasis patients [4]. The ...
BACKGROUND Increases in aminotransferases (transaminitis) are potential major adverse reactions seen...
BACKGROUND Increases in aminotransferases (transaminitis) are potential major adverse reactions seen...
Background. Methotrexate is an anchor drug in the management of rheumatoid arthritis (RA). However, ...
Seventy patients with psoriasis severe enough to require methotrexate therapy were evaluated to asse...
Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequen
Introduction and Objectives: Liver injury caused by methotrexate (MTX) has mostly been investigated ...
Background: Methotrexate, a drug used for rheumatic arthritis treatment is suspected to has hepatoto...
The objectives were to determine quantitative liver function prospectively in patients with rheumato...
BACKGROUND: Methotrexate-induced liver damage in psoriasis has led to dermatologic guidelines that s...
BACKGROUND AND DESIGN: Methotrexate (MTX) hepatotoxicity in psoriatic patients is well recognized, b...
Background:Methotrexate (MTX) is one of the most commonly used disease-modifying antirheumatic drugs...
Background Rheumatoid arhtirtis (RA) is a chronic autoimmune disease that mainly attacks joints. It ...
Contains fulltext : 50706.pdf (publisher's version ) (Closed access)BACKGROUND: Me...
The present study was undertaken to evaluate methotrexate induced early hepatotoxicity in rheumatoid...
of procollagen III peptide as a marker of hepatotoxicity in MTX-treated psoriasis patients [4]. The ...
BACKGROUND Increases in aminotransferases (transaminitis) are potential major adverse reactions seen...
BACKGROUND Increases in aminotransferases (transaminitis) are potential major adverse reactions seen...
Background. Methotrexate is an anchor drug in the management of rheumatoid arthritis (RA). However, ...
Seventy patients with psoriasis severe enough to require methotrexate therapy were evaluated to asse...
Liver injury in long-term methotrexate treatment in psoriasis is relatively infrequen
Introduction and Objectives: Liver injury caused by methotrexate (MTX) has mostly been investigated ...
Background: Methotrexate, a drug used for rheumatic arthritis treatment is suspected to has hepatoto...
The objectives were to determine quantitative liver function prospectively in patients with rheumato...